• MORE MARKET STATS

Viveka Roychowdhury

Articles By Viveka Roychowdhury

111 Articles

Pharma to see increments of 13.5 per cent: Antal International

Hiring is predicted at 64 per cent for the next quarter, as the pharma sector is seeing a lot of growth in the market with new tie-ups

Pharma to see increments of 13.5 per cent: Antal International

Quality consciousness: A pre-requisite to progress

Manufacturing quality has now become probably the single most important concern in the boardrooms of pharmaceutical companies in India

Quality consciousness: A pre-requisite to progress

‘The goal is to continue to build an internationally competitive and collaborative sector’

Sharon McKendry, Head, Scottish Development International shares details about the advantages offered to Indian lifesciences players investing in Scotland, SDI’s measures to make the business environment more conducive and

‘The goal is to continue to build an internationally competitive and collaborative sector’

Healing public healthcare

Union Minister of Health and Family Welfare JP Nadda's recent statement that "devolution, decentralisation and timely responsiveness would be the focus of the National Health Mission (NHM)" is a continuation of the move to s

Healing public healthcare

Weeding out the bad FDCs

The fixed dose combination (FDC) issue has been a contentious one for years and on March 10 came back to haunt pharma companies in India

Weeding out the bad FDCs

Once again, nothing much for pharma

In his third budget, Finance Minister Arun Jaitley has taken one more shot at a balancing act between maintaining fiscal discipline and loosening the purse strings to provide a growth impetus

Once again, nothing much for pharma

PerkinElmer revs up India diagnostics ops

With one of the highest birth rates in the world, India is one of the most obvious strategic growth markets for the prenatal and neonatal diagnostics business of PerkinElmer. Dr Prahlad Singh, President, Diagnostics, PerkinEl

PerkinElmer revs up India diagnostics ops

Debating public health priorities

A recent release from the Department of Personnel and Training, Government of India stirred up a hornet's nest

Debating public health priorities

Waiting to IPO?

Will the bullish response to last year's IPOs in the pharma and healthcare sector spur more companies to test the market in 2016? Will these hopefuls succeed in timing their IPOs just right? Or is this just hype and hope? By

Waiting to IPO?

Public health: In need of Nari Shakti

As we mark yet another Women’s Day this March, here are some sobering words from Sanghita Bhattacharyya, Senior Public Health Specialist at the Public Health Foundation of India

Public health: In need of Nari Shakti

Revival mantras for MSMEs

Precious things come in small packages (think diamonds)

Revival mantras for MSMEs

2016-17: A year for healthcare?

As the number of confirmed cases of Zika virus infection crossed the 20,000 mark in Columbia, the World Health Organization (WHO), called an emergency meeting on February 1

2016-17: A year for healthcare?

Acche Din Kab Aayenge?

All eyes are once again on India's Finance Minister Arun Jaitley as he prepares to present the Modi Government's second full budget

Acche Din Kab Aayenge?

Awakening the clinician in every radiologist

Like all professions, radiologists have their favourite T-shirt slogans. Take for instance the tongue in cheek: 'We don't see it in black and white but in different shades of gray'

Awakening the clinician in every radiologist

‘The need of the hour calls out for a mindset change on how we manage employees’

Richard Cowley, Founder, WorkAmmo, in an interview with Viveka Roychowdhury, talks about the need for leadership to support a learning culture

‘The need of the hour calls out for a mindset change on how we manage employees’

Online pharmacies both game changers and troublemakers

I’d hazard a guess that there is hardly anyone who is not a user of e-commerce platforms to ease the daily grind

Online pharmacies both game changers and troublemakers

A not so ‘sweet sixteen’?

If last year’s anniversary issue celebrated the rise and rise of India's leading corporate hospital groups and profiled the next generation, this year’s focus is more somber

A not so ‘sweet sixteen’?

KTR inaugurates Novartis Knowledge City

The Novartis Knowledge City in Hyderabad is clearly not just a testament to the value proposition offered by the Hyderabad NGSC. It is also a reminder that pharma companies are now willing to go that extra mile to attract and

KTR inaugurates Novartis Knowledge City

WL dims Sun’s shine … a bit

A new year brings with it new hope but all indications are that 2016 is going to be a mixed bag for the pharmaceutical industry

WL dims Sun’s shine … a bit

‘Make in India’ initiative could be huge re-branding opportunity

Pharma cos need people who are Indian at heart, with global expertise in tech ops says Ian Wilcox, Global Managing Director, Life Sciences, HayGroup as he spells out some growth strategies to Viveka Roychowdhury

‘Make in India’ initiative could be huge re-branding opportunity

Of laws and flaws

Could New Jersey Superior Court's decision this October be a wake up call for Indian companies with global ambitions

Of laws and flaws

‘RNTCP, state programmes could benefit from adapting more patient-centric models’

Dr Kalyan Krishna Velivela, Medical Coordinator, MSF specialises in TB, especially drug resistant TB and has recently returned from Uzbekistan which is one of the many countries in Asia with a high burden of drug-resistant TB

‘RNTCP, state programmes could benefit from adapting more patient-centric models’

High-tech vs high-touch

As we gear up for our 16th Anniversary issue this January, we decided to start a new venture: Healthcare Challengers, a platform to bring together entrepreneurs who challenge the norm in healthcare and the funders who take a

High-tech vs high-touch

Bosch, Klenzaids JV marks coming together of German quality systems and Indian value engineering

The joint venture between Bosch Packaging Technology and Klenzaids Contamination Controls, where the former will acquire a 49 per cent share in the latter, will complete a year this December. Viveka Roychowdhury gets an updat

Bosch, Klenzaids JV marks coming together of German quality systems and Indian value engineering

Sifting the trends into 2016

If the latest edition of the Antal Global Snapshot (AGS) on annual global hiring and firing trends is any indicator, hiring in India’s pharmaceutical industry is picking up and set to firm up in the next quarter

Sifting the trends into 2016

Will new IP policy ensure Sabka Vikas?

In our last issue, we highlighted Swati Spentose’s quiet rise to become a Rs 40-crore speciality API manufacturer

Will new IP policy ensure Sabka Vikas?

Building a healthier future

A recent study on malnutrition in rural Maharashtra, released recently at a two day event organised by Jan Arogya Abhiyan (JSA-Maharashtra), Anna Adhikar Abhiyan (Right to Food campaign, Maharashtra), Tata Institute of Social

Building a healthier future
Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement